tiprankstipranks
Advertisement
Advertisement

MDCX Stock Latest News

Medicus submits SkinJect Rare Pediatric Disease Designation request to FDA
The FlyMedicus submits SkinJect Rare Pediatric Disease Designation request to FDA
27d ago
MDCX
Medicus Pharma submits substantial modification application through EU CTIS
PremiumThe Fly
Medicus Pharma submits substantial modification application through EU CTIS
1M ago
MDCX
Medicus Pharma Shareholders Approve Auditor, Board and Consolidation
PremiumCompany Announcements
Medicus Pharma Shareholders Approve Auditor, Board and Consolidation
1M ago
8K
MDCX
Medicus Pharma submits Protocol SKNJCT-005 to the FDA
PremiumThe Fly
Medicus Pharma submits Protocol SKNJCT-005 to the FDA
1M ago
MDCX
Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure
PremiumCompany Announcements
Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure
2M ago
8K
MDCX
Medicus Pharma reports Q1 EPS (31c), consensus (22c)
PremiumThe FlyMedicus Pharma reports Q1 EPS (31c), consensus (22c)
2M ago
MDCX
Medicus Pharma announces results from Phase 2 SKNJCT-003 analysis
Premium
The Fly
Medicus Pharma announces results from Phase 2 SKNJCT-003 analysis
2M ago
MDCX
Medicus Pharma meets with lawmakers to support SkinJect designations
Premium
The Fly
Medicus Pharma meets with lawmakers to support SkinJect designations
3M ago
MDCX
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
PremiumRatings
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
3M ago
MDCX
Medicus Pharma Expands ATM Equity Program for Funding
PremiumCompany Announcements
Medicus Pharma Expands ATM Equity Program for Funding
3M ago
8K
MDCX
Medicus Pharma initiated with a Buy at Roth Capital
PremiumThe Fly
Medicus Pharma initiated with a Buy at Roth Capital
3M ago
MDCX
Medicus Pharma submits ODD application to U.S. FDA for SkinJect
PremiumThe Fly
Medicus Pharma submits ODD application to U.S. FDA for SkinJect
3M ago
MDCX
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
PremiumCompany AnnouncementsMedicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
3M ago
MDCX
Medicus Pharma enters media partnership with New to The Street
Premium
The Fly
Medicus Pharma enters media partnership with New to The Street
3M ago
MDCX
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
Premium
Company Announcements
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
3M ago
MDCX
Medicus Pharma submits clinical study design to FDA for Teverelix
PremiumThe Fly
Medicus Pharma submits clinical study design to FDA for Teverelix
3M ago
MDCX
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
PremiumCompany Announcements
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
3M ago
MDCX
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
PremiumCompany Announcements
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
3M ago
MDCX
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
PremiumCompany Announcements
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
3M ago
MDCX
Medicus Pharma reports principal investigator validation of Phase 2 data
PremiumThe FlyMedicus Pharma reports principal investigator validation of Phase 2 data
3M ago
MDCX
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
Premium
Company Announcements
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
4M ago
MDCX
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
Premium
Company Announcements
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
4M ago
MDCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >